Return to homepagePandemic Pact

COVID-19 IN PREGNANT WOMEN IN MIDDLE EAST

  • Funded by Swiss National Science Foundation (SNSF)
  • Total publications:0 publications

Grant number: 213489

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $95,226.37

  • Funder

    Swiss National Science Foundation (SNSF)

  • Principal Investigator

    Buess Matthias

  • Research Location

    Switzerland

  • Lead Research Institution

    Office International Relations University of Lausanne

  • Research Priority Alignment

    N/A

  • Research Category

    14

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Pregnant women

  • Occupations of Interest

    Unspecified

Abstract

To gather a large dataset, we launched an international online registry, named "COVI-Preg", providing a structured data collection tool available to any facility assessing pregnant patients for SARS-CoV-2 infection. A registration website is accessible at www.covi-preg.ch giving collaborators an access to the REDCap data collection platform available online at https://redcap.unisante.ch/ . After COVI-Preg was published in THE LANCET (PMID: 32353329), we gathered more than 150 centres worldwide including through Prof Mousavi, who provided very interesting data from Afghan pregnant patients exposed to SARS-CoV-2.Prof Mousavi data on Afghan pregnant women will also be beneficial to our hospital. He will bring important additional data to COVI-Preg as well as his expertise in molecular biology and biochemistry. His research is very complementary to the research we are currently conducting.